AEPCX
Price
$64.59
Change
+$0.34 (+0.53%)
Updated
Jun 2 closing price
Net Assets
136.57B
JIJIX
Price
$19.84
Change
+$0.18 (+0.92%)
Updated
Jun 2 closing price
Net Assets
5.03B
Interact to see
Advertisement

AEPCX vs JIJIX

Header iconAEPCX vs JIJIX Comparison
Open Charts AEPCX vs JIJIXBanner chart's image
AEPCX vs JIJIX Comparison Chart in %
View a ticker or compare two or three
VS
AEPCX vs. JIJIX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Hold and JIJIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 137B vs. JIJIX (5.03B). AEPCX pays higher dividends than JIJIX: AEPCX (2.06) vs JIJIX (0.58). AEPCX was incepted earlier than JIJIX: AEPCX (25 years) vs JIJIX (7 years). AEPCX (1.57) is less costly to investors than JIJIX (0.93). JIJIX is a more actively managed with annual turnover of: 135.00 vs. AEPCX (35.00). AEPCX has a lower initial minimum investment than JIJIX: AEPCX (250) vs JIJIX (250000). JIJIX annual gain was more profitable for investors over the last year : 34.44 vs. AEPCX (13.48). JIJIX return over 5 years is better than : 24.13 vs. AEPCX (-5.59).
AEPCXJIJIXAEPCX / JIJIX
Total Expense Ratio1.570.92171%
Annual Report Gross Expense Ratio1.570.93169%
Fund Existence25 years7 years-
Gain YTD11.21724.90545%
Front LoadN/AN/A-
Min. Initial Investment2502500000%
Min. Initial Investment IRAN/AN/A-
Net Assets137B5.03B2,725%
Annual Yield % from dividends2.060.58358%
Returns for 1 year13.4834.4439%
Returns for 3 years28.3999.5329%
Returns for 5 years-5.5924.13-23%
Returns for 10 years51.98N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
STLD271.419.82
+3.75%
Steel Dynamics
COSM0.260.01
+3.33%
Cosmos Health
NWE69.791.56
+2.28%
NorthWestern Energy Group
BBDC8.76-0.08
-0.90%
Barings BDC
RNAC6.41-0.51
-7.37%
Cartesian Therapeutics